comparemela.com
Home
Live Updates
Patients With Treatment Na - Breaking News
Pages:
Latest Breaking News On - Patients with treatment na - Page 1 : comparemela.com
Zanubrutinib Plus Sonrotoclax in Patients With Treatment-Naïve CLL/SLL
Nicole Lamanna, MD, discusses the results from the ongoing BGB-11417-101 study investigating combination zanubrutinib plus sonrotoclax in patients with treatment-naïve CLL/SLL.
Targeted therapies
B cell malignancies
Plus sonrotoclax
Patients with treatment na
Chronic lymphocytic leukemia
Cll treatments
Chronic lymphocytic leukemia treatments
Bgb 11417 101
Bcl2 inhibitor
AstraZeneca advances ambition to redefine care for blood cancer at ASH 2021
AstraZeneca will present new data underscoring its commitment to transforming haematologic cancer care at the 63rd American Society of Hematology
United states
United kingdom
Dave fredrickson
Anas younes
Acerta pharma
Idelalisib bendamustine
American society of hematology
Company on twitter astrazeneca
American society
Annual meeting
Executive vice president
Oncology business unit
Senior vice president
Calquence phase
Year follow up
Investigating acalabrutinib
vimarsana © 2020. All Rights Reserved.